Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Temozolomide-Induced Hypermutation Is Associated With Distant Recurrence and Reduced Survival After High-Grade Transformation of Low-Grade IDH-Mutant GliomasNeuro-oncology 2021 Apr 05;[EPub Ahead of Print], Y Yu, J Villanueva-Meyer, MR Grimmer, S Hilz, DA Solomon, S Choi, M Wahl, T Mazor, C Hong, A Shai, JJ Phillips, BH Wainer, M McDermott, D Haas-Kogan, JW Taylor, N Butowski, JL Clarke, MS Berger, AM Molinaro, SM Chang, JF Costello, NA Oberheim Bush
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.